Where are we with bladder preservation for muscle-invasive bladder cancer in 2017?

INTRODUCTION: In 2017, neoadjuvant, cisplatin-based chemotherapy followed by radical cystectomy (RC) is considered the gold standard therapy for muscle-invasive bladder based on randomized controlled trials. Across all tumor stages, this approach has been associated with the highest rates of disease...

Descripción completa

Detalles Bibliográficos
Autores principales: Smelser, Woodson Wade, Austenfeld, Marcus A., Holzbeierlein, Jeffrey Maxwell, Lee, Eugene Kang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2017
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5396398/
https://www.ncbi.nlm.nih.gov/pubmed/28469298
http://dx.doi.org/10.4103/iju.IJU_279_16

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5396398/
https://www.ncbi.nlm.nih.gov/pubmed/28469298
http://dx.doi.org/10.4103/iju.IJU_279_16

Ejemplares similares